Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Dendreon Gains on U.S. Panel’s Backing for Provenge Cancer Drug
Dendreon Gains on U.S. Panel’s Backing for Provenge Cancer Drug
Dendreon Gains on U.S. Panel’s Backing for Provenge Cancer Drug
Submitted by
admin
on November 18, 2010 - 9:36am
Source:
Bloomberg
News Tags:
Dendreon
prostate cancer
Provenge
Headline:
Dendreon Gains on U.S. Panel’s Backing for Provenge Cancer Drug
Do Not Allow Advertisers to Use My Personal information
